Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acidogenic intestinal flora refers to the collection of gut microorganisms, primarily bacteria, that produce organic acids, especially short-chain fatty acids (SCFAs), through the fermentation of dietary fibers and other non-digestible compounds in the colon. These bacteria play a crucial role in maintaining gut health by regulating pH, providing energy to colonocytes, and influencing immune responses. The composition and function of acidogenic flora can be significantly impacted by diet and external interventions, with imbalances linked to various diseases.
Metabolic activity of gut bacteria leading to SCFA production and other beneficial effects, influenced by diet and external interventions.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acidogenic Intestinal Flora.